β3-adrenoreceptor gene polymorphism: A newly identified risk factor for proliferative retinopathy in NIDDM patients

Diabetes

Volumn 46, Issue 10, 1997, Pages 1633-1636

  Sakane, Naoki ^a,b   Yoshida, Toshihide ^a   Yoshioka, Keiji ^a,c   Nakamura, Yoshio ^a,c   Umekawa, Tunekazu ^a   Kogure, Akinori ^a   Takakura, Yasuto ^a   Kondo, Motoharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Ayabe Municipal Hospital   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN;

ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE DIAGNOSIS; VASCULAR DISEASE;

EID: 0030754250     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.46.10.1633     Document Type: Article

References (34)

1. Klein R, Klein BEK, Moss SE, Davis MD, Demets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
2. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
3. Doft BH, Kingsley LA, Orchard TJ, Kuller L, Drash A, Becker D: The association between long-term diabetic control and early retinopathy. Ophthalmology 91:763-769, 1984
4. Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC: Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes 38:435-440, 1989
5. Stewart LL, Field LL, Ross S, McArthur RG: Genetic risk factors in diabetic retinopathy. Diabetologia 36:1293-1298, 1993
6. Cruickshanks KJ, Vadheim CM, Moss SE, Roth M-P, Riley WJ, Maclaren NK, Langfield D, Sparkers RS, Klein R, Rotter JI: Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes 41:879-885, 1992
7. n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 44:727-732, 1995
8. 3-adrenergic-receptor gene. N Engl J Med 333:343-347, 1995
9. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
10. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
11. 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 346:1433-1434, 1995
12. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39:349-352, 1996
13. 3-adrenergic receptor gene with NIDDM, current and maximal body mass index (Letter). Diabetologia 39:1410, 1996
14. 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and insulin resistance syndrome. Diabetologia 40:200-204, 1997
15. Early Treatment Diabetic Retinopathy Study Research Group: Early treatment diabetic retinopathy study design and baseline patient characteristics. Ophthalmology 98: 741-756, 1991
16. Guven D, Ozdemir H, Hasanresoglu B: Hemodynamic alterations in diabetic retinopathy. Ophthalmology 103:1245-1249, 1996
17. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39:97-102, 1996
18. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215:555-560, 1995
19. Li LS, Lönnqvist F, Luthman H, Arner P: Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860, 1996
20. 3-adrenergic receptor gene. Diabetes 45:1115-1120, 1996
21. 3-adrenergic receptor gene Trp64Arg mutation is over-represented in obese women: effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45:1358-1363, 1996
22. Berlan M, Galitzky J, Bousquet-Melou A, Lafontan M, Montastruc JL: Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther 268:1444-1451, 1994
23. Shen Y-T, Zhang H, Vatner SF: Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs. J Pharmacol Exp Ther 268:466-473, 1994
24. Atef N, Lafontan M, Doublé A, Helary C, Ktorza A, Penicaud L: A specific adrenoceptor agonist induces increased pancreati islet blood flow and insulin secretion in rats. Eur J Pharmacol 298:287-292, 1996
25. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 19:271-272, 1996
26. Nakagami T, Kawahara R, Hori S, Omori Y: Effect of diabetic control on the development of retinopathy in non-insulin-dependent diabetes mellitus: prospective follow-up study for 8 years. J Japan Diab Soc 39:901-906, 1996
27. Nakagami T, Kawahara K, Hori S, Omori Y: Glycemic control and prevention of retinopathy in Japanese NIDDM patients: a 10-year follow-up study. Diabetes Care 20:621-622, 1997
28. 3adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996
29. 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 348:698-699, 1996
30. 3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec family study and Swedish obese subjects cohorts. J Clin Invest 98:2086-2093, 1996
31. 3-adrenergic receptors (Abstract). In 10th International Congress of Endocrinology: Program and Abstracts, 1996, p. 349
32. 3-adrenergic agonist, SR 58611A (Abstract). In 10th International Congress of Endocrinology: Program and Abstracts, 1996, p. 986
33. lc) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:161-164, 1995
34. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995